German DRG (diagnosis related groups) system "wastes money and is open to fraud"
This article was originally published in Clinica
The new German diagnosis related groups (DRG) system for hospital reimbursement risks being open to abuse and creating a cost explosion in the health service, unless amendments are immediately forthcoming, says the employees sickness fund (DAK).
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.